List of Illustrations
Chapter 1
Figure 1.1 Non‐aspiration needle collection technique. Note that the mass is...
Figure 1.2 Aspiration needle collection technique. A syringe can be attached...
Figure 1.3 Transferring the sample to glass slides. Note that the bevel of t...
Figure 1.4 Spreading the sample. Rest a clean glass slide on top of the slid...
Figure 1.5 Spreading the sample. Use only the weight of the top slide, with ...
Figure 1.6 An ideal cytology slide is present on the right, with a monolayer...
Figure 1.7 Swab collection method for external ear cytology.
Figure 1.8 The swab is gently rolled along the slide to transfer material in...
Figure 1.9 Rapid Romanowsky‐type stains (Diff Quik).
Chapter 2
Figure 2.1 Cholesterol crystals, 20× objective. Note the common notched corn...
Figure 2.2 Necrotic material, 50× objective. Intact prostatic carcinoma cell...
Figure 2.3 Hemorrhage, 100× objective. A macrophage is seen with a central p...
Figure 2.4 Extracellular matrix, 50× objective. Note the bright pink, smooth...
Figure 2.5 Collagen, 50× objective. Delicate tendrils of pink collagen swirl...
Figure 2.6 Cytoplasmic fragments, 50× objective. Note the small round fragme...
Figure 2.7 Mineralized debris, 50× objective. The material is seen in differ...
Figure 2.8 Glove powder starch crystals, 50× objective. Note the characteris...
Figure 2.9 Stain precipitate, 50× objective. Stain precipitate is granular a...
Figure 2.10 Ultrasound/lubricant gel, 50× objective. Bright purple granular ...
Figure 2.11 Background crystals, 20× objective. Geometric crystals may form ...
Figure 2.12 Hemoglobin crystals, 50× objective. These crystals are needle‐sh...
Figure 2.13 Hemoglobin crystals, 50× objective. These crystals are similar i...
Figure 2.14 Blood clot, 50× objective. Clotted blood may form colorful patte...
Figure 2.15 Nuclear material, 50× objective. Note the streaming pink nuclear...
Figure 2.16 Bare nuclei, 50× objective. Nuclei from lysed cells (arrows) app...
Figure 2.17 Apoptotic cells, 100× objective. Apoptotic cells have pyknotic n...
Figure 2.18 Pollen grains, 50× objective. Skin impression smear from a dog. ...
Figure 2.19 Formalin artifact, 50× objective. Note the pale‐blue homogeneous...
Figure 2.20 Capillaries, 20× objective. Linear pink capillaries course betwe...
Figure 2.21 Capillaries, 50× objective. Pink, linear capillaries with elonga...
Figure 2.22 Mature, fat‐laden adipocytes, 50× objective.
Figure 2.23 Lipid vacuoles, 50× objective.
Figure 2.24 Keratin debris from the skin surface, 20× objective.
Figure 2.25 Skeletal muscle, 100× objective. Skeletal muscle has medium‐blue...
Figure 2.26 Normal mesothelium, 100× objective. Note the pink fringe border....
Figure 2.27 Inflammatory cells, all 100× objective. (A) Neutrophils. (B) Eos...
Figure 2.28 Degenerative neutrophils, 100× objective. Note the swollen nucle...
Figure 2.29 Toxic neutrophils, blood, cat, 100× objective. Note the cytoplas...
Figure 2.30 Apoptotic/pyknotic nuclei, 100× objective. Two apoptotic neutrop...
Figure 2.31 Epithelial cells, prostatic carcinoma, dog, 50× objective. Cells...
Figure 2.32 Mesenchymal cells, leiomyosarcoma, cat, 50× objective.
Figure 2.33 Mesenchymal cells, osteosarcoma, dog, 50× objective. The neoplas...
Figure 2.34 Round cell tumor, mast cell tumor, dog, 50× objective.
Figure 2.35 Round cell tumor, histiocytoma, dog, 50× objective. The cells ar...
Figure 2.36 Poorly cohesive carcinoma (hepatocellular carcinoma), dog, 50× o...
Figure 2.37 Malignant melanoma, dog, 50× objective. The cells are vaguely co...
Figure 2.38 Benign mesenchymal neoplasia, fibroma, dog, 50× objective. Note ...
Figure 2.39 Benign epithelial neoplasia, mammary adenoma, dog, 50× objective...
Figure 2.40 Anisocytosis, mesothelioma, dog, 50× objective. Note the variati...
Figure 2.41 Cell piling, perianal gland carcinoma, dog, 50× objective. The c...
Figure 2.42 Cell cannibalism, mesothelioma, dog, 50× objective. A mitotic ne...
Figure 2.43 High N/C ratios, mammary carcinoma, dog, 50× objective.
Figure 2.44 Anisokaryosis, transitional cell carcinoma, dog, 50× objective. ...
Figure 2.45 Multinucleation, anaplastic sarcoma with giant cells, cat, 50× o...
Figure 2.46 Satellite nuclei, histiocytic sarcoma, dog, 50× objective. Note ...
Figure 2.47 Nuclear fragmentation, histiocytic sarcoma, dog, 50× objective....
Figure 2.48 Hyperchromasia, osteosarcoma, dog, 50× objective. Note how dark ...
Figure 2.49 Prominent nucleoli, histiocytic sarcoma, dog, 50× objective.
Figure 2.50 Multiple nucleoli, osteosarcoma, dog, 100× objective. Note the v...
Figure 2.51 Stages of normal mitosis. (A) Prophase. (B) Metaphase (end on). ...
Figure 2.52 Bizarre mitotic figure, histiocytic sarcoma, dog, 100× objective...
Figure 2.53 Giant and complex mitosis, soft tissue sarcoma, dog, 50× objecti...
Chapter 3
Figure 3.1 Cryptococcus neoformans, cat, 50× objective. Note the narrow base...
Figure 3.2 Cryptococcus neoformans, cat, 50× objective. Two organisms are ph...
Figure 3.3 Cryptococcus neoformans, cat, 50× objective. Multiple organisms w...
Figure 3.4 Histoplasma capsulatum, cat, 100× objective. Abundant organisms s...
Figure 3.5 Sporothrix schenkii, cat, 100× objective. Organisms seen within a...
Figure 3.6 Dermatophytes, dog, 100× objective. Small basophilic organisms wi...
Figure 3.7 Blastomyces dermatitidis, dog, 100× objective.
Figure 3.8 Coccidioides immitis spherule, dog, 50× objective. Note the large...
Figure 3.9 Coccidioides immitis, dog, 50× objective. Note the spherule conta...
Figure 3.10 Candida albicans, dog, 100× objective, urine. Note the elongated...
Figure 3.11 Pneumocystis spp., dog, 100× objective. Note the small size rela...
Figure 3.12 Pneumocystis spp., dog, 100× objective. The characteristic ring ...
Figure 3.13 Malassezia, dog, 100× objective.
Figure 3.14 Cyniclomyces guttulatus, dog, 50× objective. Three organisms in ...
Figure 3.15 Penicillium spp., dog, 50× objective. Note the brush‐like appear...
Figure 3.16 Aspergillus spp. hyphae, dog, 20× objective. Note the characteri...
Figure 3.17 Phaeohyphomycosis, dog, 50× objective. The hyphae have a charact...
Figure 3.18 Phaeohyphomycosis, dog, 50× objective (same case as Figure 3.17)...
Figure 3.19 Pythium insidiosum hyphae, dog, 100× objective. Note the charact...
Figure 3.20 Prototheca, dog, 100× objective.
Figure 3.21 Diatoms, dog, 50× objective, bronchoalveolar lavage. The organis...
Figure 3.22 Rhinosporidium seeberi endospores (arrows), dog, 100× objective,...
Figure 3.23 Neospora caninum, dog, 100× objective. Multiple crescent‐shaped ...
Figure 3.24 Toxoplasma gondii, dog, 100× objective. Three extracellular cres...
Figure 3.25 Leishmania spp., dog, 100× objective. Note the characteristic ‘T...
Figure 3.26 Cytauxzoon felis schizont, cat, 100× objective. A large macropha...
Figure 3.27 Cytauxzoon felis, cat, peripheral blood, 100× objective. Note th...
Figure 3.28 Giardia lamblia trophozoite, dog, 100× objective.
Figure 3.29 Giardia lamblia cysts, dog, 50× objective.
Figure 3.30 Tritrichomonas fetus, cat, 100× objective, feces. Note the flage...
Figure 3.31 Blastocystis spp., dog, 50× objective, feces. Note the large cen...
Figure 3.32 Cryptosporidium canis oocysts, dog, 100× objective, Kinyoun acid...
Figure 3.33 Hepatozoon americanum, dog, peripheral blood, 100× objective.
Figure 3.34 Mesocestoides, abdominal fluid gross appearance, dog. Note the g...
Figure 3.35 Mesocestoides, abdominal fluid, dog, 20× objective. Note the ref...
Figure 3.36 Filaroides hirthi, dog, 50× objective.
Figure 3.37 Aelurostrongylus abstrusus, cat, 50× objective. Note the promine...
Figure 3.38 Dracunculus, dog, 20× objective.
Figure 3.39 Paragonimus kellicotti, cat, 40× objective.
Figure 3.40 Mycobacteria spp., cat, 100× objective. A macrophage contains nu...
Figure 3.41 Mycobacteria spp., dog, 100× objective. Macrophages are distende...
Figure 3.42 Mycobacteria spp., dog, 100× objective, acid‐fast stain (same ca...
Figure 3.43 Actinomyces spp., cat, 100× objective. Note the long, fine, bran...
Figure 3.44 Bordetella bronchiseptica, dog, 100× objective. Note the basophi...
Figure 3.45 Anaplasma phagocytophilum, dog, 100× objective. A morula of baso...
Figure 3.46 Neorickettsia helminthoeca (salmon poisoning disease), lymph nod...
Figure 3.47 Clostridium perfringens, dog, 100× objective. Note the character...
Figure 3.48 Campylobacter spp., dog, 100× objective. Note the small, ‘gull‐w...
Figure 3.49 Helicobacter spp., dog, 100× objective. Note the large size and ...
Figure 3.50 Simonsiella‐like bacteria, dog, 100× objective. Bacteria are pre...
Figure 3.51 Cuterebra spp., cat, 20× objective. Note the branching, annular ...
Figure 3.52 Cuterebra spp., cat, 20× objective. Note the cylindrical, circul...
Figure 3.53 Demodex canis nymph, dog, 50× objective.
Figure 3.54 Sarcoptes scabii, dog, 20× objective.
Figure 3.55 Otodectes cynotis, dog, 20× objective.
Chapter 4
Figure 4.1 Mast cell tumor, dog, 40× objective. Note the linear ribbons of b...
Figure 4.2 Mast cell tumor, dog, 50× objective. Two reactive fibroblasts (ce...
Figure 4.3 Mast cell tumor (histologic grade III, high grade), dog, 50× obje...
Figure 4.4 Mast cell tumor, dog, 50× objective. Note the variable granulatio...
Figure 4.5 Mast cell tumor (histologic grade III, high grade), dog, 50× obje...
Figure 4.6 Mast cell tumor (histologic grade III, high grade), dog, 50× obje...
Figure 4.7 Mast cell tumor, dog, 50× objective, Diff Quik stain. Although gr...
Figure 4.8 Mast cell tumor, cat, 50× objective.
Figure 4.9 Mast cell tumor, cat, 50× objective. Note the more subtle, fine g...
Figure 4.10 Mast cell tumor, cat, 50× objective, Diff Quik stain. Granules s...
Figure 4.11 Mast cell tumor, cat, 50× objective. This aggressive tumor conta...
Figure 4.12 Histiocytoma, dog, 50× objective. Note the abundant watery blue ...
Figure 4.13 Histiocytoma, dog, 50× objective. Note the abundant watery blue ...
Figure 4.14 Regressing histiocytoma, dog, 50× objective. Note the many small...
Figure 4.15 Histiocytic sarcoma, dog, 50× objective. Note the prominent cyto...
Figure 4.16 Histiocytic sarcoma, dog, 50× objective. Note the nuclear pleomo...
Figure 4.17 Cutaneous lymphoma, dog, 50× objective. Note the high N/C ratios...
Figure 4.18 Cutaneous lymphoma (granular), dog, 50× objective. Note the peri...
Figure 4.19 Cutaneous lymphoma, dog, 50× objective. Large, neoplastic lympho...
Figure 4.20 Merkel cell carcinoma, dog, 50× objective. The cells are seen bo...
Figure 4.21 Plasmacytoma, dog, 50× objective. Note the moderate background o...
Figure 4.22 Plasmacytoma, dog, 50× objective. Note the prominent perinuclear...
Figure 4.23 Plasmacytoma, dog, 50× objective.
Figure 4.24 Plasmacytoma, dog, 50× objective. Note the peripheralized pink c...
Figure 4.25 Plasmacytoma, dog, 50× objective. Note the frequent binucleation...
Figure 4.26 Transmissible venereal tumor, dog, 50× objective. Note the promi...
Figure 4.27 Transmissible venereal tumor, dog, 50× objective. The cells have...
Figure 4.28 Melanocytoma, dog, 50× objective. Note the abundant green/black ...
Figure 4.29 Malignant melanoma, dog, 50× objective. Cells mostly lack pigmen...
Figure 4.30 Malignant melanoma (poorly melanotic), dog, 50× objective. Note ...
Figure 4.31 Infundibular/epidermal cyst, dog, 10× objective. Many anucleated...
Figure 4.32 Infundibular/epidermal cyst, dog, 20× objective. Keratinized deb...
Figure 4.33 Pigmented hair shafts/bulbs, dog, 50× objective. Note the differ...
Figure 4.34 Infundibular/epidermal cyst, dog, 20× objective. Aggregates of a...
Figure 4.35 Cutaneous basilar epithelial neoplasm (trichoblastoma), dog, 50×...
Figure 4.36 Cutaneous basilar epithelial neoplasm (trichoepithelioma), dog, ...
Figure 4.37 Cutaneous basilar epithelial neoplasm (trichoblastoma; granular ...
Figure 4.38 Basal cell carcinoma, cat, 50× objective. Note the cell piling a...
Figure 4.39 Sweat gland adenoma, dog, 50× objective.
Figure 4.40 Sweat gland adenocarcinoma, dog, 50× objective.
Figure 4.41 Sebaceous adenoma, dog, 50× objective.
Figure 4.42 Sebaceous epithelioma, dog, 50× objective.
Figure 4.43 Sebaceous carcinoma, dog, 50× objective. Note the fine clear vac...
Figure 4.44 Cutaneous metastatic carcinoma (pulmonary carcinoma), cat, 50× o...
Figure 4.45 Squamous papilloma, dog, 50× objective. Note the characteristic ...
Figure 4.46 Squamous cell carcinoma, cat, 50× objective. Note the sky‐blue c...
Figure 4.47 Perianal gland adenoma, dog, 50× objective. Smaller reserve cell...
Figure 4.48 Perianal gland adenocarcinoma, dog, 50× objective. Note the high...
Figure 4.49 Anal sac apocrine gland adenocarcinoma, dog, 50× objective.
Figure 4.50 Clear cell adnexal carcinoma, dog, 50× objective. Note the promi...
Figure 4.51 Reactive fibroplasia, dog, 50× objective. Note the accompanying ...
Figure 4.52 Fibroma, dog, 50× objective.
Figure 4.53 Fibrosarcoma, dog, 50× objective.
Figure 4.54 Keloidal fibroma, dog, 20× objective. Note the characteristic la...
Figure 4.55 Soft tissue sarcoma (perivascular wall tumor), dog, 20× objectiv...
Figure 4.56 Soft tissue sarcoma (perivascular wall tumor), dog, 50× objectiv...
Figure 4.57 Soft tissue sarcoma (perivascular wall tumor), dog, 50× objectiv...
Figure 4.58 Grade III soft tissue sarcoma, dog, 50× objective. Note the mult...
Figure 4.59 Hemangioma, dog, 50× objective. Note the bloody background, spin...
Figure 4.60 Hemangiosarcoma (cutaneous), dog, 50× objective. Note the increa...
Figure 4.61 Hemangiosarcoma (cutaneous), dog, 50× objective. Note the promin...
Figure 4.62 Myxoma, dog, 50× objective. Note the dense pink, streaming mucin...
Figure 4.63 Myxosarcoma, dog, 50× objective. Note the dense pink stippled, m...
Figure 4.64 Anaplastic sarcoma with giant cells, cat, 50× objective.
Figure 4.65 Lipoma, dog, 4× objective.
Figure 4.66 Lipoma, dog, 20× objective. Note the streaming, linear capillari...
Figure 4.67 Liposarcoma (well differentiated), dog, 10× objective.
Figure 4.68 Liposarcoma (poorly differentiated), dog, 50× objective. The cel...
Figure 4.69 Liposarcoma, dog, 50× objective. Note the prominent coarse clear...
Figure 4.70 Xanthoma, dog, 50× objective. Macrophages are monomorphic and fr...
Figure 4.71 Reactive fibrohistiocytic nodule, dog, 50× objective. Note the r...
Figure 4.72 Sterile nodular panniculitis, dog, 50× objective. Note the abund...
Figure 4.73 Steatitis, dog, 50× objective. Mixed inflammation is centered ar...
Figure 4.74 Pyogranulomatous inflammation, dog, 50× objective. Note the larg...
Figure 4.75 Vaccine reaction (rabies vaccine), dog, 50× objective. Note the ...
Figure 4.76 Abscess, cat, 100× objective. Neutrophils are degenerative and c...
Figure 4.77 Seroma, dog, 50× objective. Macrophages contain phagocytosed pro...
Figure 4.78 Calcinosis circumscripta, dog, 20× objective. Note the thick bac...
Figure 4.79 Calcinosis circumscripta (gross appearance), dog. The samples ha...
Figure 4.80 Calcinosis cutis, dog, 50× objective.
Figure 4.81 Hypersensitivity reaction, dog, 50× objective. Note the mast cel...
Figure 4.82 Eosinophilic granuloma, cat, 50× objective. Note the abundant eo...
Figure 4.83 Pemphigus foliaceus, dog, 50× objective. Numerous acantholytic c...
Figure 4.84 Pemphigus foliaceus, dog, 50× objective. Acantholytic cells surr...
Chapter 5
Figure 5.1 Lymph node (normal), cat, 50× objective. Small lymphocytes consti...
Figure 5.2 Lymph node (normal), cat, 50× objective.
Figure 5.3 Lymph node (reactive), dog, 50× objective. Note the variation in ...
Figure 5.4 Lymph node (reactive), dog, 50× objective.
Figure 5.5 Lymph node (reactive), dog, 50× objective. Note that mitotic figu...
Figure 5.6 Lymph node, neutrophilic lymphadenitis from puppy with juvenile c...
Figure 5.7 Lymph node, septic neutrophilic lymphadenitis, 100× objective. No...
Figure 5.8 Lymph node, eosinophilic lymphadenitis, dog, 50× objective. Note ...
Figure 5.9 Lymph node, Neorickettsia helminthoeca (salmon poisoning disease)...
Figure 5.10 Lymph node, large‐cell lymphoma, dog, 50× objective. Note the la...
Figure 5.11 Lymph node, large‐cell lymphoma, cat, 50× objective. The cells a...
Figure 5.12 Lymph node, large‐cell lymphoma, dog, 50× objective. Note the sm...
Figure 5.13 Lymph node, large‐cell lymphoma, dog, 50× objective. Diff‐Quik s...
Figure 5.14 Lymph node, small‐cell lymphoma, dog, 50× objective. Note the ex...
Figure 5.15 Lymph node, small‐cell lymphoma, dog, 100× objective. The more o...
Figure 5.16 Lymph node, small‐cell lymphoma (T‐zone), dog, 50× objective. No...
Figure 5.17 Lymph node, lymphoblastic lymphoma, dog, 60× objective. Note the...
Figure 5.18 Lymph node, lymphoblastic lymphoma, dog, 50× objective. Note the...
Figure 5.19 Lymph node, lymphoma with Mott cell differentiation, dog, 50× ob...
Figure 5.20 Lymph node, Hodgkin’s‐like lymphoma, cat, 50× objective. Most ly...
Figure 5.21 Lymph node, Hodgkin’s‐like lymphoma, cat, 50× objective. Note th...
Figure 5.22 Lymph node, acute leukemia infiltration, dog, 60× objective. Acu...
Figure 5.23 Lymph node, metastatic squamous cell carcinoma, dog, 50× objecti...
Figure 5.24 Lymph node, metastatic mast cell tumor, dog, 50× objective. The ...
Figure 5.25 Lymph node, metastatic transmissible venereal tumor, dog, 50× ob...
Figure 5.26 Lymph node, metastatic amelanotic melanoma, dog, 50× objective....
Figure 5.27 Lymph node, metastatic fibrosarcoma, dog, 50× objective.
Figure 5.28 Spleen (normal), dog, 20× objective. Note the large stromal aggr...
Figure 5.29 Spleen, benign nodular hyperplasia, dog, 20× objective. An aggre...
Figure 5.30 Spleen, benign nodular hyperplasia, dog, 50× objective. The mixe...
Figure 5.31 Spleen, extramedullary hematopoiesis, dog, 50× objective. Erythr...
Figure 5.32 Spleen, myelolipoma, cat, 20× objective. Note the abundant lipid...
Figure 5.33 Spleen, myelolipoma, dog, 50× objective. Lipid vacuoles are seen...
Figure 5.34 Spleen, hemangiosarcoma, dog, 20× objective. Note the spindle ce...
Figure 5.35 Spleen, hemangiosarcoma, dog, 40× objective.
Figure 5.36 Spleen, large‐cell lymphoma, dog, 50× objective.
Figure 5.37 Spleen, large‐cell lymphoma, dog, 50× objective. Note the numero...
Figure 5.38 Spleen, marginal zone lymphoma, dog, 50× objective. Note the lar...
Figure 5.39 Spleen, hepatosplenic lymphoma, dog, 100× objective. Note the pe...
Figure 5.40 Spleen, acute granulocytic leukemia, dog, 50× objective.
Figure 5.41 Spleen, acute erythroid leukemia, cat, 50× objective. Note the d...
Figure 5.42 Spleen, chronic lymphocytic leukemia (CLL), dog, 50× objective....
Figure 5.43 Spleen, myeloma‐like disease, cat, 50× objective.
Figure 5.44 Spleen, histiocytic sarcoma, dog, 50× objective.
Figure 5.45 Spleen, hemophagocytic histiocytic sarcoma, dog, 50× objective. ...
Figure 5.46 Spleen, visceral mast cell neoplasia, cat, 50× objective.
Figure 5.47 Spleen, metastatic hepatocellular carcinoma, dog, 20× objective....
Figure 5.48 Spleen, metastatic fibrosarcoma, dog, 50× objective.
Figure 5.49 Spleen, metastatic mast cell neoplasia, dog, 50× objective.
Figure 5.50 Spleen, amyloid, cat, 20× objective. Note the bright‐purple fibr...
Figure 5.51 Spleen, dog, 50× objective. Hemophagocytic syndrome with numerou...
Figure 5.52 Thymus, thymoma, dog, 20× objective. Mixed lymphocytes surround ...
Figure 5.53 Thymus, thymoma, dog, 50× objective. Note the mixed lymphoid pop...
Figure 5.54 Thymus, thymic carcinoma, dog, 50× objective. The cells have a d...
Figure 5.55 Thymus, lymphoma, dog, 50× objective. Note the irregular nuclear...
Figure 5.56 Thymus, branchial cyst, 50× objective. Note the ciliated epithel...
Figure 5.57 Erythroid precursor cells from youngest to most mature. (A) Rubr...
Figure 5.58 Granulocytic precursor cells from youngest to most mature. (A) M...
Figure 5.59 Megakaryocytic precursor cells from youngest to most mature. (A)...
Figure 5.60 Bone marrow, acute granulocytic leukemia (AML‐M2), dog, 50× obje...
Figure 5.61 Bone marrow, acute granulocytic leukemia (AML‐M2; same case as F...
Figure 5.62 Bone marrow, acute myelomonocytic leukemia (AML‐M4), dog, 50× ob...
Figure 5.63 Bone marrow, acute erythroid leukemia (AML‐M6Er), cat, 100× obje...
Figure 5.64 Bone marrow, acute megakaryoblastic leukemia (AML‐M7), dog, 50× ...
Figure 5.65 Bone marrow, acute lymphoid leukemia, dog, 50× objective.
Figure 5.66 Bone marrow, metastatic large‐cell lymphoma, dog, 50× objective....
Figure 5.67 Bone marrow, granulocytic hyperplasia, cat, 50× objective. The s...
Figure 5.68 Bone marrow, erythroid hyperplasia, dog, 50× objective. Increase...
Figure 5.69 Bone marrow, hemophagocytosis, dog, 50× objective. Precursor‐tar...
Figure 5.70 Bone marrow, hemophagocytic histiocytic sarcoma, dog, 50× object...
Figure 5.71 Bone marrow, histiocytic sarcoma, dog, 50× objective. Note the l...
Figure 5.72 Bone marrow, plasmacytosis, dog, 50× objective. Increased number...
Figure 5.73 Bone marrow, Leishmaniasis, dog, 100× objective. Note the Leishm...
Figure 5.74 Bone marrow, chronic lymphocytic leukemia (CLL), dog, 50× object...
Figure 5.75 Bone marrow, multiple myeloma, dog, 50× objective.
Figure 5.76 Bone marrow, metastatic carcinoma (prostatic), dog, 20× objectiv...
Figure 5.77 Bone marrow, metastatic carcinoma (prostatic), dog, 50× objectiv...
Figure 5.78 Bone marrow, metastatic mast cell neoplasia, dog, 50× objective....
Figure 5.79 Bone marrow, hypoplasia, dog, 10× objective.
Chapter 6
Figure 6.1 Low protein transudate, dog, 50× objective.
Figure 6.2 Septic exudate (bacterial peritonitis), dog, 100× objective. Note...
Figure 6.3 Sterile neutrophilic exudate from dog with pancreatitis, 100× obj...
Figure 6.4 Eosinophilic exudate, cat, 50× objective.
Figure 6.5 High protein exudate, cat, 10× objective. Note the thick, protein...
Figure 6.6 Bile peritonitis, dog, 50× objective. Note the aggregates of gree...
Figure 6.7 White bile peritonitis, dog, 20× objective. Note the large aggreg...
Figure 6.8 Chylous effusion, cat, 50× objective. Note the abundant, variably...
Figure 6.9 Lymphocyte‐rich effusion, cat, 50× objective. Note the variation ...
Figure 6.10 Uroabdomen, septic, dog, 100× objective.
Figure 6.11 Hemorrhagic effusion, dog, 50× objective. Reactive macrophages c...
Figure 6.12 Reactive mesothelial cell, dog, 50× objective. Classic features ...
Figure 6.13 Reactive mesothelial hyperplasia, dog, 50× objective. Note the f...
Figure 6.14 Reactive mesothelial hyperplasia, dog, 50× objective.
Figure 6.15 Mesothelioma, dog, 50× objective. Note the neoplastic cell that ...
Figure 6.16 Mesothelioma, dog, 50× objective. Neoplastic cells contain golde...
Figure 6.17 Mesothelioma, dog, 50× objective. Note the angular cell shape an...
Figure 6.18 Carcinoma, abdominal fluid, cat, 20× objective. Note the enormou...
Figure 6.19 Carcinoma, pleural fluid, cat, 50× objective. There is a bizarre...
Figure 6.20 Carcinoma, pleural fluid, cat, 50× objective. Note the multinucl...
Figure 6.21 Lymphoma, pleural effusion, dog, 50× objective.
Figure 6.22 Histiocytic sarcoma, pericardial effusion, dog, 50× objective.
Figure 6.23 Mast cell neoplasia, abdominal fluid, dog, 50× objective. Note t...
Figure 6.24 Mast cell neoplasia, pleural fluid, dog, 50× objective. The nume...
Chapter 7
Figure 7.1 Bone, osteoma, cat, 50× objective. Numerous well‐differentiated o...
Figure 7.2 Bone, osteosarcoma, dog, 50× objective. Note the smooth to fibril...
Figure 7.3 Bone, osteosarcoma, dog, 50× objective. Many criteria of malignan...
Figure 7.4 Bone, osteosarcoma, dog, 100× objective. Note the ovoid, neoplast...
Figure 7.5 Bone, chondrosarcoma, dog, 50× objective. Neoplastic cells are em...
Figure 7.6 Bone, multilobular osteochondrosarcoma, dog, 50× objective.
Figure 7.7 Bone, hemangiosarcoma, dog, 50× objective.
Figure 7.8 Bone, fibrosarcoma, dog, 50× objective.
Figure 7.9 Bone, histiocytic sarcoma, dog, 50× objective.
Figure 7.10 Bone, multiple myeloma, dog, 100× objective. Lytic lesion in spi...
Figure 7.11 Bone, metastatic mammary carcinoma, dog, 50× objective. Note the...
Figure 7.12 Bone, osteomyelitis, dog, 50× objective. Fungal organisms are se...
Figure 7.13 Synovial fluid (normal), dog, 50× objective. There is a medium‐p...
Figure 7.14 Synovial fluid, dog, 20× objective. Mononuclear inflammation and...
Figure 7.15 Synovial fluid, dog, 100× objective. Septic arthritis. Note bact...
Figure 7.16 Synovial fluid, dog, 100× objective. Rickettsial infection. Note...
Figure 7.17 Synovial fluid, dog, 50× objective. Sterile neutrophilic inflamm...
Figure 7.18 Synovial fluid, dog, 100× objective. IMPA with ragocytes. Note t...
Figure 7.19 Synovial fluid, dog, 100× objective. Systemic lupus erythematosu...
Figure 7.20 Synovial fluid, dog, 50× objective. Metastatic histiocytic sarco...
Figure 7.21 Synovial fluid, dog, 50× objective. Metastatic bronchogenic carc...
Figure 7.22 Synovial fluid, dog, 100× objective. Hemarthrosis. Note the bloo...
Figure 7.23 Synovial cyst, dog, 50× objective. Note the thick pink mucinous ...
Figure 7.24 Synovial sarcoma, dog, 50× objective.
Figure 7.25 Periarticular histiocytic sarcoma, dog, 50× objective.
Figure 7.26 Rhabdomyoma, dog larynx, 50× objective. Note the faint pink gran...
Figure 7.27 Rhabdomyosarcoma (embryonal), dog, 50× objective.
Figure 7.28 Rhabdomyosarcoma (differentiated), dog, 20× objective. Note the ...
Figure 7.29 Rhabdomyosarcoma (differentiated), dog, 50× objective. Many cell...
Figure 7.30 Leiomyoma, dog, vagina, 50× objective.
Figure 7.31 Leiomyosarcoma, cat, stomach, 50× objective.
Chapter 8
Figure 8.1 Normal hepatocytes, dog, 50× objective.
Figure 8.2 Normal hepatocytes, dog, 100× objective. Note the rectangular cry...
Figure 8.3 Non‐lipid (glycogen) vacuolar hepatopathy, dog, 50× objective.
Figure 8.4 Hepatic lipidosis, cat, 20× objective.
Figure 8.5 Hepatic lipidosis, cat, 50× objective.
Figure 8.6 Liver, dog, 50× objective. Nodular hyperplasia.
Figure 8.7 Hepatoma, dog, 50× objective.
Figure 8.8 Hepatocellular carcinoma (well differentiated), dog, 50× objectiv...
Figure 8.9 Hepatocellular carcinoma (well differentiated), dog, 50× objectiv...
Figure 8.10 Hepatocellular carcinoma (high grade), dog, 50× objective.
Figure 8.11 Liver, carcinoid, dog, 50× objective.
Figure 8.12 Liver, metastatic mast cell neoplasia, dog, 50× objective. The m...
Figure 8.13 Liver, metastatic mammary carcinoma, cat, 50× objective. Note th...
Figure 8.14 Liver, metastatic fibrosarcoma, dog, 50× objective.
Figure 8.15 Liver, lymphoma (large‐cell), dog, 50× objective. Large lymphocy...
Figure 8.16 Liver, lymphoma (large‐cell), dog, 50× objective. Note the fine ...
Figure 8.17 Liver, lymphoma (small‐cell), dog, 50× objective. Compare the op...
Figure 8.18 Liver, inflammation (lymphocytic), cat, 50× objective.
Figure 8.19 Liver, inflammation (lymphoplasmacytic), cat, 50× objective. Man...
Figure 8.20 Liver, inflammation (neutrophilic), dog, 50× objective.
Figure 8.21 Lipofuscin pigment, dog, 50× objective. Note the diffuse, blue‐g...
Figure 8.22 Cholestasis and bile pigment, dog, 50× objective. Note the green...
Figure 8.23 Hemosiderin pigment, dog, 50× objective. Note the golden‐brown a...
Figure 8.24 Copper pigment, dog, 100× objective. The pigment is refractile a...
Figure 8.25 Rhodanine stain highlighting copper pigment in hepatocytes, dog,...
Figure 8.26 Amyloid, dog, 50× objective. Note the bright magenta, fibrillar ...
Figure 8.27 Biliary epithelial hyperplasia, cat, 50× objective.
Figure 8.28 Biliary cystadenoma, cat, 20× objective. Note the abundant smoot...
Figure 8.29 Bile duct carcinoma (cholangiocarcinoma), cat, 50× objective. No...
Figure 8.30 Bactibilia, dog, 50× objective. Numerous small, blue bacterial c...
Chapter 9
Figure 9.1 Normal salivary gland epithelium, dog, 50× objective. Note the ti...
Figure 9.2 Salivary gland adenoma, dog, 40× objective. Note the higher N/C r...
Figure 9.3 Salivary gland adenocarcinoma, cat, 50× objective.
Figure 9.4 Sialocoele, dog, 20× objective. Note the smooth pools of pale‐blu...
Figure 9.5 Sialadenitis, dog, 50× objective.
Figure 9.6 Intestine, lymphoplasmacytic inflammation, cat, 100× objective.
Figure 9.7 Intestine, lymphoma (small‐cell), dog, 50× objective.
Figure 9.8 Intestine, lymphoma (small‐cell), cat, 50× objective. The cells h...
Another random document with no related content on Scribd:
